Join
Live feed
·
INSIDERFilingvia Quantisnow
Halozyme Therapeutics Inc. logo

SVP, CHIEF OPERATING OFFICER Caudill Cortney exercised 21,546 shares at a strike of $33.51 and sold $1,955,160 worth of shares (28,857 units at $67.75), decreasing direct ownership by 51% to 7,055 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HALO (Halozyme Therapeutics Inc.) and more on Quantisnow.